BIODESIX, INC. Gain (Loss) on Disposition of Assets
BIODESIX, INC. (BDSX) reported Gain (Loss) on Disposition of Assets of -$48.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2021-03-16
- BIODESIX, INC. gain (loss) on disposition of assets for fiscal 2020 was -$48.00K.
- BIODESIX, INC. gain (loss) on disposition of assets for fiscal 2019 was -$13.00K.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2020-12-31 | -$48.00K 10-K · filed 2021-03-16 |
| 2019-12-31 | -$13.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |